NASDAQ:APRE   Aprea Therapeutics, Inc.
not much to describe here.
I will just give it a try with a tight stop-loss.
expecting it to fill the gap.

the drop back in dec happened because one of its clinical trials did not succeed.
but they still work on others.
nice move today.
profit can be taken, +50% is not bad at all.
but I will wait for more.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.